ArticleAnnals of surgical oncology2025

Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast Cancers.

Leah Winer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.